Home/Filings/4/0001104659-23-024801
4//SEC Filing

Ellis Christopher 4

Accession 0001104659-23-024801

CIK 0001828185other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:54 PM ET

Size

5.7 KB

Accession

0001104659-23-024801

Insider Transaction Report

Form 4
Period: 2023-01-03
Ellis Christopher
Chief Operating Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2023-01-03+105,000105,000 total
    Exercise: $2.40Exp: 2033-01-03Ordinary Shares (105,000 underlying)
Footnotes (2)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.

Issuer

Vaccitech plc

CIK 0001828185

Entity typeother

Related Parties

1
  • filerCIK 0001851664

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:54 PM ET
Size
5.7 KB